Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Comment by digger144on Jul 25, 2012 6:28pm
253 Views
Post# 20152524

RE: New COO at BRD

RE: New COO at BRD

I cannot believe this...honestly...totally unexpected!

https://www.agnico-eagle.com/Theme/Agnico2/files/images/person%20high%20rez/5413_DanielRacine_644_SU_CMYK.jpg

Now...if you were looking for any reassurrance as to why you bought this stock or why you should buy this stock...then...this latest announcement should strengthen your belief and confidence in the story...or..if you are sitting on the fence...what are you waiting for!

Besides the gold in the ground, in my opinion the addition of Daniel Racine as COO to the Brigus Team can be considered as a most tremendous asset moving forward.

Just think for a minute...he has been with Agnico Eagle for over 20 years and was recently promoted to Senior Vice-President in February, 2012...why would he make the move...there is no doubt that he is up to the challenge and using his broad knowledge and experience which was built in his tenure with AEM, he concluded that there is something special here.

As for AEM their flagship operation is the Laronde Mine in Quebec...guess what...Daniel Racine was the Mine Manager there at one point of his career with them...Nice!

Well...as I posted, I presently hold 50,000 shares @ $.86 which I purchased in late June, 2012....tomorrow morning, I will be looking to add more!

What else can I say...I cannot wait for him to join the Brigus Team...Fantastic News!

Digger144

P.S. Am I excited...you bet!

By the way...he will more than likely attract others to join him that will build the Brigus

Team moving forward...this is just great news!

Bullboard Posts